1/15
Comprehensive vocabulary flashcards detailing the normal serum values, underlying etiologies, clinical manifestations, and evidence-based nursing interventions for sodium, potassium, calcium, and magnesium imbalances.
Hyponatremia
A serum sodium level less than 135mEq/L (135mmol/L), primarily occurring due to an imbalance of water rather than sodium (dilutional hyponatremia), which causes water to move into cells and produce cellular swelling.
Maximum Safe Sodium Correction Rate
The clinical threshold requiring that serum sodium must not be increased by more than 12mEq/L in 24 hours during sodium replacement therapy in order to prevent neurologic damage caused by demyelination.
Hypernatremia
A serum sodium level exceeding 145mEq/L (145mmol/L) and serum osmolality greater than 300mOsm/kg, resulting from excess sodium gain or water loss that pulls fluid out of cells and causes cellular shrinkage.
Hypokalemia
A serum potassium level below 3.5mEq/L, commonly caused by potassium-losing diuretics, GI losses, corticosteroids, or metabolic alkalosis, with levels below 3mEq/L posing a risk of death via cardiac or respiratory arrest.
Intravenous Potassium Administration Rule
The nursing safety protocol dictating that potassium is never administered by IV push or intramuscularly to prevent fatal cardiac events, and must always be delivered using an infusion pump at prescribed rates (typically 40 to 80mEq/day).
Hyperkalemia
A serum potassium level greater than 5mEq/L (5mmol/L), most often caused by decreased renal excretion, cellular shifts from acidosis or tissue trauma, and posing severe risks of ventricular arrhythmias and cardiac arrest.
Kayexalate
A cation exchange resin administered either orally or by retention enema to bind potassium in the gastrointestinal tract and promote its excretion to treat hyperkalemia.
Ionized Calcium
The physiologically active, unbound fraction comprising approximately 50% of total serum calcium (4.5 to 5.1mg/dL or 1.1 to 1.3mmol/L) critical for neuromuscular activity and blood coagulation.
Hypocalcemia
A total serum calcium level below 8.6mg/dL, frequently caused by hypoparathyroidism, acute pancreatitis, acute kidney injury, or massive administration of citrated blood.

Chvostek sign and Trousseau sign
Classic clinical signs of hypocalcemia and hypomagnesemia: Chvostek sign is a contraction of facial muscles elicited by a light tap over the facial nerve in front of the ear; Trousseau sign is a carpopedal spasm induced by inflating a blood pressure cuff above systolic blood pressure.
Calcium Gluconate vs. Calcium Chloride
Parenteral calcium replacement salts; calcium gluconate is preferred for IV administration, whereas calcium chloride is rarely used because it is irritating and can cause severe tissue sloughing if extravasation occurs.
Hypercalcemia
A total serum calcium level higher than 10.2mg/dL, most commonly resulting from hyperparathyroidism or malignancies, with overt manifestations typically emerging when levels reach approximately 16mg/dL (4mmol/L) or greater.
Calcitonin
A therapeutic hormone administered to treat hypercalcemia by decreasing bone resorption and increasing the deposition of calcium and phosphorus into skeletal bone tissue.
Hypomagnesemia
A serum magnesium level dropping below 1.8mg/dL, caused by gastrointestinal losses, chronic alcohol abuse, or deficient nutritional formulas, which causes neuromuscular excitability and ECG abnormalities such as QRS prolongation and ST segment depression.
Magnesium Sulfate IV Infusion Limit
The critical safety rate restriction specifying that intravenous magnesium sulfate must be administered using an infusion pump at a rate not exceeding 150mg/min (or 67mEq over 8 hours) to prevent heart block or asystole.
Hypermagnesemia
A serum magnesium level exceeding 2.6mg/dL, most commonly caused by kidney injury or excessive antacid use (e.g., Maalox), leading to central nervous system depression, hypotension, hypoactive reflexes, and respiratory depression.